Medical news
-
From protocols to demo videos: the WFH Laboratory Manual on the eLearning Platform
The World Federation of Hemophilia (WFH) is pleased to showcase the Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual, the definitive how-to guide...
-
WFH World Bleeding Disorders Registry kick-off webinar and live training opportunities
On December 12, 2017, the WFH hosted a webinar for people across the globe interested in learning more about participating in the WFH World Bleeding...
-
First case of an anti-drug antibody reported in Hemlibra trial
Roche has reported that a young patient in the HAVEN 2 clinical trial for Hemlibra (emicizumab) has developed an anti-drug antibody to Hemlibra resulting in...
-
Update from Roche on Hemlibra (emicizumab)
Update from Roche on Hemlibra (emicizumab), for more information please click here.
-
Update on Shire and Roche/Genentech patent dispute regarding Hemlibra
Update: On March 28, 2018, Chugai Pharmaceuticals, a subsidiary of Roche, announced that a Japanese court ruled that the hemophilia treatment product Hemlibra (emicizumab) does...
-
New and Updated: The Guide for the Assessment of Clotting Factor Concentrates, 3rd edition
Determining the safety and quality of therapeutic products for the treatment of hemophilia is crucial for the optimal treatment of patients. The World Federation of...
-
The WFH Compendium of Assessment Tools – The Toolbox for Hemophilia HCPs and Researchers
The World Federation of Hemophilia (WFH) Compendium of Assessment Tools-found on the WFH eLearning Platform-is an invaluable resource for researchers and healthcare professionals. A summary...
-
WFH Online Registry of Clotting Factor Concentrates
The Online Registry of Clotting Factor Concentrates on the World Federation of Hemophilia (WFH) eLearning Platform puts the details of over 100 products at your...
-
WBDR to go live this January
The World Federation of Hemophilia (WFH) World Bleeding Disorders Registry (WBDR) will go live with the enrollment of the first patient into the patient registry on...
-
WFH closely monitoring Shire and Roche/Genentech patent dispute
The World Federation of Hemophilia has been closely monitoring the developing situation between Shire and Roche/Genentech and their dispute over patent ownership. We will continue...
